Abstract:Background: Identifying novel regulatory factors and uncovered mechanisms of somatic cell reprogramming will be helpful for basic research and clinical application of induced pluripotent stem cells (iPSCs). Sin3a, a multifunctional transcription regulator, has been proven to be involved in the maintenance of pluripotency in embryonic stem cells (ESCs), but the role of Sin3a in somatic cell reprogramming remains unclear. Methods: RNA interference of Sin3a during somatic cell reprogramming was realized by short hairpin RNAs. Reprogramming efficiency was evaluated by the number of alkaline phosphatase (AP)-positive colonies and Oct4-GFP-positive colonies. RNA sequencing was performed to identify the influenced biological processes after Sin3a knockdown and further confirmed by quantitative RT-PCR (qRT-PCR), western blotting and flow cytometry. The interaction between Sin3a and Tet1 was detected by coimmunoprecipitation. The enrichment of Sin3a and Tet1 at the epithelial gene promoters was measured by chromatin immunoprecipitation. Furthermore, DNA methylation patterns at the gene loci were investigated by hydroxymethylated DNA immunoprecipitation. Finally, Sin3a mutants that disrupt the interaction of Sin3a and Tet1 were also introduced to assess the importance of the Sin3a-Tet1 interaction during the mesenchymal-to-epithelial transition (MET) process. Results: We found that Sin3a was gradually increased during OSKM-induced reprogramming and that knockdown of Sin3a significantly impaired MET at the early stage of reprogramming and iPSC generation. Mechanistic studies showed that Sin3a recruited Tet1 to facilitate the hydroxymethylation of epithelial gene promoters. Moreover, disrupting the interaction of Sin3a and Tet1 significantly blocked MET and iPSC generation. Conclusions: Our studies revealed that Sin3a was a novel mediator of MET during early reprogramming, where Sin3a functioned as an epigenetic coactivator, cooperating with Tet1 to activate the epithelial program and promote the initiation of somatic cell reprogramming. These findings highlight the importance of Sin3a in the MET process and deepen our understanding of the epigenetic regulatory network of early reprogramming.

Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2 Proteins Regulate the Mesenchymal-to-Epithelial Transition of Somatic Cell Reprogramming

Nuclear-cytoplasmic Shuttling of Class IIa Histone Deacetylases Regulates Somatic Cell Reprogramming

A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

MicroRNA-mediated regulation of extracellular matrix formation modulates somatic cell reprogramming.

The mesenchymal-to-epithelial transition in somatic cell reprogramming

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Reprogramming Fibroblasts Toward Cardiomyocytes, Neural Stem Cells and Hepatocytes by Cell Activation and Signaling-Directed Lineage Conversion

A Conserved Role of Shp2 in Regulation of Human and Mouse Es Cell Differentiation

KDM4B-mediated Reduction of H3K9me3 and H3K36me3 Levels Improves Somatic Cell Reprogramming into Pluripotency

TFAP2C facilitates somatic cell reprogramming by inhibiting c-Myc-dependent apoptosis and promoting mesenchymal-to-epithelial transition

Coordinated repression of totipotency-associated gene loci by histone methyltransferase EHMT2 through binding to LINE-1 regulatory elements

Tet and TDG Mediate DNA Demethylation Essential for Mesenchymal-to-epithelial Transition in Somatic Cell Reprogramming.

Chromatin remodeling and its epigenetic regulatory mechanisms in cell fate transition

Combinatorial targeting of a specific EMT/MET network by macroH2A variants safeguards mesenchymal identity

Targeting Mll1 H3K4 Methyltransferase Activity to Guide Cardiac Lineage Specific Reprogramming of Fibroblasts

Restricting Epigenetic Activity Promotes the Reprogramming of Transformed Cells to Pluripotency in a Line-Specific Manner

Metabolic switch and epithelial–mesenchymal transition cooperate to regulate pluripotency

Biphasic Regulation of Mesenchymal Genes Controls Fate Switches During Hematopoietic Differentiation of Human Pluripotent Stem Cells

Critical Regulation of Mir-200/Zeb2 Pathway in Oct4/Sox2-induced Mesenchymal-to-epithelial Transition and Induced Pluripotent Stem Cell Generation

LMCD1 Facilitates the Induction of Pluripotency Via Cell Proliferation, Metabolism, and Epithelial‐mesenchymal Transition

Sin3a drives mesenchymal-to-epithelial transition through cooperating with Tet1 in somatic cell reprogramming